BOLD FY 2023 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$55M

Net Income

-$49M

EPS (Diluted)

$-2.22

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$130M

Total Liabilities

$257M

Stockholders' Equity

-$127M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$55M	-$46M	-17.9%
Net Income	-$49M	-$46M	-7.7%